| Bioactivity | SARS-CoV-2 Mpro-IN-14 (Compound 19) is an inhibitor of SARS-CoV-2 Mpro with an IC50 of 0.044 μM. SARS-CoV-2 Mpro-IN-14 exhibits water solubility, has no cytotoxicity, and can be used in the study of COVID-19[1]. |
| Target | IC50: 0.044 μM (SARS-CoV-2 Mpro) |
| Name | SARS-CoV-2 Mpro-IN-14 |
| CAS | 2679814-93-6 |
| Formula | C28H19Cl2FN4O4 |
| Molar Mass | 565.38 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zhang CH, et al. Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency. ACS Med Chem Lett. 2021 Jul 14;12(8):1325-1332. |
SARS-CoV-2 Mpro-IN-14
CAS: 2679814-93-6 F: C28H19Cl2FN4O4 W: 565.38
SARS-CoV-2 Mpro-IN-14 (Compound 19) is an inhibitor of SARS-CoV-2 Mpro with an IC50 of 0.044 μM. SARS-CoV-2 Mpro-IN-14
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.